IL13 and Increased total eosinophil count: In the presence of IL-25 or IL-33, ILC2s can directly control the key features of type 2 asthma, including eosinophilia, bronchial hyperreactivity, and goblet cell hyperplasia, by producing IL-5, IL-9, and IL-13 (110).